To prevent potential employee discrimination lawsuits, companies are crafting ever-more inclusive policies regarding sexual and gender identity. But this is a sensitive topic with many unresolved details. David Bogoslaw reports.
Relatively young, technology-based companies face special difficulties when dealing with crises. Their focus on market disruption and their lack of established credibility make earning public trust even more difficult. And yet, LendingClub shows how it can be done at a time when Theranos certainly failed the crisis management test. David Bogoslaw has more.
An EU-U.S. privacy protection standard is supposed to gain approval in June, but concerns—namely with the U.S.’s ongoing surveillance efforts and mass data collection—could delay approval, leaving thousands of companies that rely on cross-border data transfers in legal limbo. David Bogoslaw explores.
Employers are taking longer and longer to act on internal whistleblower reports, which can frustrate employees who have been encouraged to step up and report what they see as unacceptable behavior. As reporters find their concerns languishing in limbo, the chances they might simply take their issue to an outside agency increases. But it doesn’t have to be this way. David Bogoslaw reports.
Plenty of research supports the notion of mandatory retirement age for board members, but what about MRPs for CEOs? Does imposing an age limit on top executives really drive better long-term organizational performance? Shareholders, it turns out, seem to prefer experience to youth.
Valeant Pharmaceuticals’ announced financial restatement raises questions about the drug company’s compliance program and its business model. But it might also serve as an early warning to all publicly listed U.S. companies about the increased room for misjudging the booking of sales once FASB rolls out its new revenue recognition standards in 2019.